By Colin Young March 24, 2026
As we move through 2026, the biopharma industry is hitting a major sustainability milestone. For years, the move to Single-Use Technology (SUT) was criticized for its plastic waste. Today, one step towards solving that paradox that has been presented is Bio-based Polymers.
Here’s why this matters for your next scale-up:
The “Drop-In” Advantage
Modern bio-based plastics (like Bio-PP and Bio-PE) are chemically identical to their petroleum-based ancestors. This means zero re-validation of your process—you get the same USP <88> Class VI performance with a fraction of the carbon footprint.
Decoupling from Fossil Fuels
By using feedstocks like used cooking oil or wood pulp residue, the industry is significantly lowering its Scope 3 emissions. Leading suppliers like Cytiva and Dow have already begun integrating these into commercial lab and filtration products this year.
Safety Without Compromise
Confusion alert: Bio-based is NOT the same as Biodegradable. In bioprocessing, we need durability. Bio-based plastics are just as rugged as traditional plastics; they won’t break down during a 21-day run, but they can be recycled through the same advanced circular economy streams.
In 2026, being an expert in deployment means being an expert in the materials that power our industry.
Are you looking to implement single-use technology, but concerned about the environmental impact? Let’s talk solutions.